TGF-beta signalling in colon carcinogenesis

被引：128
|
作者：
Lampropoulos, Pavlos [1 ]
Zizi-Sermpetzoglou, Adamantia [2 ]
Rizos, Spyros [1 ]
Kostakis, Alkiviadis [3 ]
Nikiteas, Nikolaos [3 ]
Papavassiliou, Athanasios G. [4 ]
机构：
[1] Tzaneio Gen Hosp, Dept Surg 1, Athens, Greece
[2] Tzaneio Gen Hosp, Dept Pathol, Athens, Greece
[3] Univ Athens, Sch Med, Dept Propaedeut Surg 2, GR-11527 Athens, Greece
[4] Univ Athens, Sch Med, Dept Biol Chem, GR-11527 Athens, Greece
来源：
CANCER LETTERS | 2012年 / 314卷 / 01期
关键词：
TGF-beta signalling pathway; Colorectal cancer (CRC); Targeted therapy; GROWTH-FACTOR BETA-1; HUMAN COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; SOLUBLE BETAGLYCAN; TUMOR-SUPPRESSOR; LIVER METASTASIS; GENE-MUTATIONS; IMMUNE CELLS; II RECEPTOR; SMAD4;
D O I：
10.1016/j.canlet.2011.09.041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Colorectal cancer remains the most common cancer and the second leading cause of cancer mortality in Europe. There are a number of pathways that have been implicated in colorectal carcinogenesis, including TGF-beta (TGF-beta)/Smad signalling pathway. The TGF-beta pathway is involved in several biological processes, including cell proliferation, differentiation, migration and apoptosis. Here we review the role of TGF-beta signalling cascade in colorectal carcinogenesis and provide some new molecular insights that may aid efforts towards targeted antitumor therapies. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：1 / 7
页数：7
相关论文
共 50 条
  • [1] TGF-beta Signalling and Tooth Development
    Huang, Xiao Feng
    Chai, Yang
    [J]. CHINESE JOURNAL OF DENTAL RESEARCH, 2010, 13 (01): : 7 - 15
  • [2] TGF-BETA IN LIVER DEVELOPMENT, REGENERATION, AND CARCINOGENESIS
    FAUSTO, N
    MEAD, JE
    GRUPPUSO, PA
    BRAUN, L
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 593 : 231 - 242
  • [3] TGF-beta signalling through the Smad pathway
    Massague, J
    Hata, A
    Liu, F
    [J]. TRENDS IN CELL BIOLOGY, 1997, 7 (05) : 187 - 192
  • [4] A mutant TGF-beta receptor causes loss of the functional TGF-beta signalling complex and resistance to TGF-beta growth inhibition by a dominant negative effect
    Knaus, PI
    DeCoteau, JF
    Kadin, ME
    Lodish, HF
    [J]. BLOOD, 1995, 86 (10) : 1710 - 1710
  • [5] Modifying TGF-beta Signalling and MEK Inhibition in Melanoma
    Smith, M. P.
    Ferguson, J. E.
    Chapman, A.
    Hurlstone, A.
    Arozarena, I.
    Wellbrock, C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S71 - S71
  • [6] Synthetic triterpenoids activate TGF-beta/SMAD signalling
    Suh, N
    Roberts, A
    Heiss, E
    Place, A
    Williams, C
    Risingsong, R
    Reffey, S
    Honda, T
    Gribble, G
    Miyazono, K
    Itoh, S
    ten Dijke, P
    Sporn, M
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1230S - 1230S
  • [7] A transcriptional partner for MAD proteins in TGF-beta signalling
    Chen, X
    Rubock, MJ
    Whitman, M
    [J]. NATURE, 1996, 383 (6602) : 691 - 696
  • [8] MAD-related proteins in TGF-beta signalling
    Wrana, JL
    Attisano, L
    [J]. TRENDS IN GENETICS, 1996, 12 (12) : 493 - 496
  • [9] Tetracycline regulatable transgenic mouse model for TGF-beta signalling: Inhibition of TGF-beta pathway in hematopoietic cells by dominant negative TGF-beta receptor II.
    Mikkola, H
    Valdimarsdottir, G
    Andersson, E
    Larsson, J
    Jacobsen, SE
    ten Dijke, P
    Karlsson, S
    [J]. BLOOD, 1999, 94 (10) : 686A - 686A
  • [10] MACROPHAGE PRODUCTION OF TGF-BETA AND REGULATION BY TGF-BETA
    WAHL, SM
    MCCARTNEYFRANCIS, N
    ALLEN, JB
    DOUGHERTY, EB
    DOUGHERTY, SF
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 593 : 188 - 196
12345